Ketas capsules 10 mg 1000 capsules from Japan

General information about Japanese Ketas capsules 10 mg 1000 capsules

Package: 1000 capsules

Manufacturer: Kyorin Pharmaceutical Co., Ltd

Active ingredient: Ibudilast

Medical effect: Ketas capsules are used for the treatment of bronchial asthma and cerebrovascular disorder. They have the following effects:

• improving cerebrovascular disorder,
• increasing action on cerebral blood flow,
• relieving dizziness induced by an after effect of cerebral infarction,
• inhibiting damage induced by glutamic acid on the hippocampal nerve,
• suppressing inflammation of respiratory tract,
• relieving airway hypersensitivity.

Contraindications and precautions:

Do not use in patients with present intracranial hemorrhages. Do not use in children, pregnant or breastfeeding women. Use with caution in patients with liver hypofunction and elderly people. If an allergic reaction occurs, stop using the product and consult with your doctor.  Store away from direct sunlight, heat and moisture.

Administration and dosage of Ketas capsules 10 mg 1000 capsules from Japan

Patients with bronchial asthma should take 1 capsule 2 times a day. Patients with cerebrovascular disorder should take 1 capsule 3 times a day.

Is Japanese Ketas capsules 10 mg 1000 capsules effective medicine?

Ketas capsules 10 mg 1000 capsules from Japan contain ibudilast, an inhibitor of certain nucleotides. Ibudilast has multiple anti-inflammatory, vasorelaxant, bronchodilator, analgesic and neuroprotective activities. Ketas capsules were approved in Japan for the treatment of bronchial asthma and cerebrovascular disorder. Ibudilast suppresses inflammation of respiratory tract and, by this, relieves airway hypersensitivity.

Multiple studies also show that Ketas capsules from Japan are effective for treatment of the after effects of cerebral infarction and cerebrovascular disorders (Y. Kishi, S. Ohta et al. Ibudilast: A Non-selective PDE Inhibitorwith Multiple Actions on Blood Cellsand the Vascular Wall. Cardiovascular Drug ReviewsVol. 19, No. 3, pp. 215 –225; T. Mizuno, T. Kurotani et al. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology, Volume 46, Issue 3, March 2004, Pages 404-411).